Covetrus, Inc. (CVET) Stock

About Covetrus, Inc.

Covetrus, Inc. functions as a technology and services provider for the animal health sector. The company supplies a comprehensive range of animal health consumables, including its own branded and proprietary items, along with diverse equipment (small and large), laboratory supplies, and associated repair services. It further offers a full spectrum of pharmaceuticals—encompassing branded, generic, and vaccine products, surgical instruments, diagnostic kits, infection control solutions, parasiticides, and nutritional supplements—to both wholesale and retail clients. Beyond physical goods, Covetrus delivers critical value-added services such as inventory management, e-commerce platforms, and professional development programs for veterinary practitioners. Its technology portfolio includes practice management software, data analytics applications, and client communication tools aimed at boosting operational efficiency and enhancing business health. These integrated offerings extend to client reminders, data backup, hardware sales and support, and credit card processing capabilities for veterinary practices and clinics. Additionally, the company manages the distribution of finished pharmaceutical products and offers specialty compounding services, complemented by logistics, manufacturer incentives, and data integration support. Covetrus supports veterinary practices and animal health clinics across the companion animal, equine, and livestock sectors, primarily within North America, Europe, and the Asia Pacific. Established in 2018 under the name HS Spinco, Inc. and headquartered in Portland, Maine, Covetrus, Inc. transitioned to private ownership on October 13, 2022.

the stock is valued at a price-to-earnings (P/E) ratio of -33.32, price-to-book of 1.90, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $13.39 and $21.20, and currently trades at its 52-week high.

On profitability, Covetrus, Inc. generates a return on equity (ROE) of -5.69%, return on capital employed of -0.81%, an operating margin of -0.48%, a net profit margin of -1.88%.

Official website: www.covetrus.com